Dyne Therapeutics, Inc. is a biotechnology company based in Waltham, Massachusetts, dedicated to developing innovative therapies for genetically-driven muscle diseases. The company leverages its proprietary muscle-targeted delivery platform to discover and advance potential treatments aimed at addressing significant unmet medical needs in this niche therapeutic area. With a robust pipeline of candidates, Dyne Therapeutics is positioned to make a substantial impact in the field of muscle diseases and improve the quality of life for affected patients.
Click "Analyze" to generate stock analysis
DYN Price Trend and Signals
DYN Option Volumes & Open Interests (aggregated)
DYN Put Call Ratios and IV (aggregated)
DYN Financials
2025-10-28Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.